Experience

1859

• United States
• Biotechnology Research
• 1 - 100 Employee

• Senior scientist DEL

  • Jul 2023 - Present

• Scientist DEL synthesis/method development

  • Mar 2022 - Jul 2023



Raybow

• China
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• synthetic chemist II

  • May 2020 - Aug 2021



Calibr at Scripps Research

• United States
• Biotechnology Research
• 1 - 100 Employee

• Postdoctoral Fellow, Medicinal Chemist

  • Dec 2016 - May 2020

  Development of MST1 inhibitors for the treatment of T1D small molecule STING agonists Development of MST1 inhibitors for the treatment of T1D small molecule STING agonists



Scripps Research

• United States
• Research Services
• 700 & Above Employee

• Research Associate

  • Nov 2015 - Nov 2016

  Development of new heterocyclic kappa opioid receptor (KOR) antagonists in the laboratory of Prof. Edward Roberts (departmen of chemistry, TSRI) Development of new heterocyclic kappa opioid receptor (KOR) antagonists in the laboratory of Prof. Edward Roberts (departmen of chemistry, TSRI)



CSIC

• Research
• 700 & Above Employee

• Research associate

  • May 2013 - Oct 2015

  Development of small peptides and foldamers as new antileishmaniasis agents Inhibition of protein-protein interactions (PPI). Development of anti-chikungunya heterocyclic compounds Development of small peptides and foldamers as new antileishmaniasis agents Inhibition of protein-protein interactions (PPI). Development of anti-chikungunya heterocyclic compounds